Prognostic value of lymphocyte-to-monocyte ratio in ovarian cancer: A meta-analysis

41Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background:Lymphocyte-to-monocyte ratio (LMR) was recently proposed as a prognostic factor of ovarian cancer. However, prognostic value of the LMR in ovarian cancer remains inconclusive. The study aimed to assess prognostic value of the LMR in ovarian cancer.Methods:Seven common databases were comprehensively searched for relevant studies. The analyses were performed for overall survival (OS), progression-free survival (PFS) and clinical parameters. The hazard ratio (HR) and 95% confidence interval (CI) were used to analyze OS and PFS.Results:A total of 2343 patients with ovarian cancer were included in this meta-analysis. The results showed that a low LMR predicted shorter OS (HR=1.81, 95% CI=1.38-2.37, P

Cite

CITATION STYLE

APA

Lu, C., Zhou, L., Ouyang, J., Yang, H., & Ding, J. (2019). Prognostic value of lymphocyte-to-monocyte ratio in ovarian cancer: A meta-analysis. Medicine (United States), 98(24). https://doi.org/10.1097/MD.0000000000015876

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free